Morning Overview on MSN
Common enzyme tied to diabetes may unlock bold new Alzheimer’s treatment
A protein that has long frustrated diabetes researchers is suddenly at the center of a very different fight. By targeting an enzyme called protein tyrosine phosphatase 1B, or PTP1B, scientists are ...
Structural models of PLD3 and PLD4, enzymes that degrade nucleic acids in the cytoplasm. The enzymes' active (or binding) sites are indicated with black arrows. LA JOLLA, CA—When nucleic acids like ...
Drug molecules and biofuels can be made to order by living cell factories, where biological enzymes do the job. Now researchers at Chalmers University of Technology have developed a computer model ...
A protein long implicated in diabetes and obesity may hold the key to treating Alzheimer’s disease by reinvigorating the brain’s immune system. New research suggests that blocking this protein, known ...
Enzymes with specific functions are becoming increasingly important in industry, medicine and environmental protection. For ...
The inhibition of an enzyme associated with neurodegeneration processes reduced the toxic effect of tau, one of the proteins that damage neurons in Alzheimer’s disease (AD). A group of scientists from ...
Human induced pluripotent stem cell (iPSC)-derived motor neurons (in green) co-cultured with iPSC-derived astrocytes (in red). [VIB] Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s ...
The partnership combines Ginkgo's AI/ML and enzyme engineering expertise with Prozomix's wealth of enzyme sequence data to create best-in-class enzymes for API manufacturing This agreement also marks ...
Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, including heart disease and fatty liver disease. Rates of these disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results